With multiple high-level CRO work in progress, personally think the clinical trial market could be the early outlier to drive growth as much as nascent Pulse sales.
One or two good contracts, significant partner announcement, potential licensing deal(s), global regulatory/OTC, viral retail uptake...there's enough there individually and in combination to keep the market interested/guessing.
Billions can wait. First step is get financially stabilized and commercially established in the US, go from there.
No real hurry, just get it right.
Add to My Watchlist
What is My Watchlist?
